Literature DB >> 32365348

Loss of Snord116 impacts lateral hypothalamus, sleep, and food-related behaviors.

Marta Pace1, Matteo Falappa1,2, Andrea Freschi1, Edoardo Balzani1, Chiara Berteotti3, Viviana Lo Martire3, Fatemeh Kaveh4, Eivind Hovig4,5, Giovanna Zoccoli3, Roberto Amici6, Matteo Cerri6, Alfonso Urbanucci4, Valter Tucci1.   

Abstract

Imprinted genes are highly expressed in the hypothalamus; however, whether specific imprinted genes affect hypothalamic neuromodulators and their functions is unknown. It has been suggested that Prader-Willi syndrome (PWS), a neurodevelopmental disorder caused by lack of paternal expression at chromosome 15q11-q13, is characterized by hypothalamic insufficiency. Here, we investigate the role of the paternally expressed Snord116 gene within the context of sleep and metabolic abnormalities of PWS, and we report a significant role of this imprinted gene in the function and organization of the 2 main neuromodulatory systems of the lateral hypothalamus (LH) - namely, the orexin (OX) and melanin concentrating hormone (MCH) - systems. We observed that the dynamics between neuronal discharge in the LH and the sleep-wake states of mice with paternal deletion of Snord116 (PWScrm+/p-) are compromised. This abnormal state-dependent neuronal activity is paralleled by a significant reduction in OX neurons in the LH of mutant mice. Therefore, we propose that an imbalance between OX- and MCH-expressing neurons in the LH of mutant mice reflects a series of deficits manifested in the PWS, such as dysregulation of rapid eye movement (REM) sleep, food intake, and temperature control.

Entities:  

Keywords:  Epigenetics; Neuroscience

Mesh:

Substances:

Year:  2020        PMID: 32365348      PMCID: PMC7406246          DOI: 10.1172/jci.insight.137495

Source DB:  PubMed          Journal:  JCI Insight        ISSN: 2379-3708


  72 in total

1.  Behavioral correlates of activity in identified hypocretin/orexin neurons.

Authors:  Boris Y Mileykovskiy; Lyudmila I Kiyashchenko; Jerome M Siegel
Journal:  Neuron       Date:  2005-06-02       Impact factor: 17.173

2.  Hypocretin deficiency in Prader-Willi syndrome.

Authors:  S Nevsimalova; J Vankova; I Stepanova; E Seemanova; E Mignot; S Nishino
Journal:  Eur J Neurol       Date:  2005-01       Impact factor: 6.089

3.  Discharge of identified orexin/hypocretin neurons across the sleep-waking cycle.

Authors:  Maan Gee Lee; Oum K Hassani; Barbara E Jones
Journal:  J Neurosci       Date:  2005-07-13       Impact factor: 6.167

4.  The changing purpose of Prader-Willi syndrome clinical diagnostic criteria and proposed revised criteria.

Authors:  M Gunay-Aygun; S Schwartz; S Heeger; M A O'Riordan; S B Cassidy
Journal:  Pediatrics       Date:  2001-11       Impact factor: 7.124

5.  Rapid eye movements sleep as a predictor of functional outcome after stroke: a translational study.

Authors:  Marta Pace; Millene R Camilo; Andrea Seiler; Simone B Duss; Johannes Mathis; Mauro Manconi; Claudio L Bassetti
Journal:  Sleep       Date:  2018-10-01       Impact factor: 5.849

Review 6.  Lateral hypothalamus as a sensor-regulator in respiratory and metabolic control.

Authors:  Denis Burdakov; Mahesh M Karnani; Antonio Gonzalez
Journal:  Physiol Behav       Date:  2013-04-03

7.  Prader-Willi syndrome: consensus diagnostic criteria.

Authors:  V A Holm; S B Cassidy; M G Butler; J M Hanchett; L R Greenswag; B Y Whitman; F Greenberg
Journal:  Pediatrics       Date:  1993-02       Impact factor: 7.124

8.  A Transcriptomic Signature of the Hypothalamic Response to Fasting and BDNF Deficiency in Prader-Willi Syndrome.

Authors:  Elena G Bochukova; Katherine Lawler; Sophie Croizier; Julia M Keogh; Nisha Patel; Garth Strohbehn; Kitty K Lo; Jack Humphrey; Anita Hokken-Koelega; Layla Damen; Stephany Donze; Sebastien G Bouret; Vincent Plagnol; I Sadaf Farooqi
Journal:  Cell Rep       Date:  2018-03-27       Impact factor: 9.423

Review 9.  Genomic Imprinting and Physiological Processes in Mammals.

Authors:  Valter Tucci; Anthony R Isles; Gavin Kelsey; Anne C Ferguson-Smith
Journal:  Cell       Date:  2019-02-21       Impact factor: 41.582

10.  Deletion of the Snord116/SNORD116 Alters Sleep in Mice and Patients with Prader-Willi Syndrome.

Authors:  Glenda Lassi; Lorenzo Priano; Silvia Maggi; Celina Garcia-Garcia; Edoardo Balzani; Nadia El-Assawy; Marco Pagani; Federico Tinarelli; Daniela Giardino; Alessandro Mauro; Jo Peters; Alessandro Gozzi; Graziano Grugni; Valter Tucci
Journal:  Sleep       Date:  2016-03-01       Impact factor: 5.849

View more
  5 in total

Review 1.  Diagnosis and management of sleep disorders in Prader-Willi syndrome.

Authors:  Jessica Duis; Lara C Pullen; Maria Picone; Norman Friedman; Stephen Hawkins; Elise Sannar; Anna C Pfalzer; Althea Robinson Shelton; Deepan Singh; Phyllis C Zee; Daniel G Glaze; Amee Revana
Journal:  J Clin Sleep Med       Date:  2022-06-01       Impact factor: 4.324

Review 2.  Epigenetics in Prader-Willi Syndrome.

Authors:  Aron Judd P Mendiola; Janine M LaSalle
Journal:  Front Genet       Date:  2021-02-15       Impact factor: 4.599

3.  Phylogenetic and Molecular Analyses Identify SNORD116 Targets Involved in the Prader-Willi Syndrome.

Authors:  Laeya Baldini; Anne Robert; Bruno Charpentier; Stéphane Labialle
Journal:  Mol Biol Evol       Date:  2022-01-07       Impact factor: 16.240

4.  Neurobehavioral Dimensions of Prader Willi Syndrome: Relationships Between Sleep and Psychosis-Risk Symptoms.

Authors:  Kathleen P O'Hora; Zizhao Zhang; Ariana Vajdi; Leila Kushan-Wells; Zhengyi Sissi Huang; Laura Pacheco-Hansen; Elizabeth Roof; Anthony Holland; Ruben C Gur; Carrie E Bearden
Journal:  Front Psychiatry       Date:  2022-04-13       Impact factor: 5.435

Review 5.  A Comprehensive Review of Genetically Engineered Mouse Models for Prader-Willi Syndrome Research.

Authors:  Delf-Magnus Kummerfeld; Carsten A Raabe; Juergen Brosius; Dingding Mo; Boris V Skryabin; Timofey S Rozhdestvensky
Journal:  Int J Mol Sci       Date:  2021-03-31       Impact factor: 5.923

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.